IN FOCUS FEATURE
North Carolina Agriculture Offers Rice to Improve Baby Formula
FROM OUR WEB SITE
North Carolina Agriculture Offers Rice to Improve Baby Formula
Ventria Bioscience is using 335 acres of Washington County farmland for rice production. The rice has been adapted to produce two specialized proteins that work to protect children's digestive tracts and, in some cases, their lives. These proteins are found in breast milk, but not baby formula.
Read more about Ventria's new agricultural biotech endeavor in this week's In Focus.
From Our Web Site
Aldagen/UC Davis Team Up to Treat Stroke
Durham-based Aldagen is collaborating with the University of California Davis Health System to study Aldagen's adult stem cells in treating stroke and other neurological disorders.
How Big is NC's Biosciences Cluster? Help Us Find Out
The Biotechnology Center has launched its annual BioSciNC survey. The survey is the basis of the company listings on our Web site.
CED's Venture Sign-Up Due
Entrepreneurs who have started North Carolina biotechnology companies can strut their stuff for venture and angel investors. Apply before December 19 to CED's 26th Annual Venture Conference.
RTP names U.S. Headquarters for GSK
After years of maintaining dual U.S. headquarters, GlaxoSmithKline has designated its sprawling Research Triangle Park campus as its official U.S. headquarters, dropping Philadelphia from the shared role.
Cornerstone Goes Public
Cary's Cornerstone BioPharma completes a merger with Critical Therapeutics, creating a new publicly traded company, Cornerstone Therapeutics.
Center Staff Speaks to Science Teachers
The National Science Teachers Association's area fall conference in Charlotte welcomed three Biotechnology Center staff members as speakers. They talked about biotechnology's application across industries and in North Carolina.
Site Mag: NC Best (Again)
The November issue of Site Selection magazine has crowned North Carolina as the state with the best business climate -- for the seventh time in the past eight years.
Clinical Trials Group to Meet in Greenville
The Clinical Trials Regional Exchange Group will hold their next meeting November 13 at the The Ronald G. Michels Center in Greenville.
Salix Drug Gets FDA OK
Morrisville-based Salix Pharmaceuticals has received marketing approval from the FDA and plans to start sales early next year of its APRISO (mesalamine), a preventative treatment for ulcerative colitis.
Biotech 2009 Ready for Business
Join the annual celebration of North Carolina's biotechnology industry Feb. 16-17 in Raleigh. Early registration has opened for the annual conference.
UNC StudiesBreast Cancer Rates
The University of North Carolina at Chapel Hill has launched a 44-county study across the state to better understand why breast cancer is more prevalent and more lethal among African-American women.
Aldagen Gets Orphan OK
A stem-cell therapy, ALD-101, developed by Durham's Aldagen, gets orphan drug status.
Parion Signs $25M Pact
Durham start-up Parion Sciences gets up to $25 million in clinical support from its Korean partner, Kainos Medicines.
CCC Encouraging Biodiesel Production with Workshop
Piedmont Biofuels of Pittsboro will teach people how to mix their own fuel and begin a business at Craven Community College this week.
From New Bern Sun-Journal
First Results from MURDOCK Study Revealed at San Francisco Conference
The team has identified a set of proteins that may be able to predict who will most likely respond to standard therapy for hepatitis C infection.
From Salisbury Post
Greenville Drug Maker Expands
Metrics plans an $18-million expansion — including several laboratories, two packaging lines and a tablet press — and will add at least 50 jobs to its staff.
From the (Raleigh) News & Observer
Magazine: N.C. Has Best Business Climate
For the fourth year in a row -- and seventh time in eight years -- North Carolina received top honors from Site Selection magazine for its ability to lure companies.
From the (Raleigh) News & Observer
From Local Tech Wire
RTP Startup Entegrion Launches Sales of Blood-loss Dressing
The company is launching commercial sales of its proprietary bandages that are designed to promote blood clotting.
From Local Tech Wire
The Research Triangle Park: 50 Years of Innovation
The state has long been a solid backer of biotechnology growth, and is now ranked third in the country.
From PharmaWeek
Community Watch
Community Watch will return next week. Please send items to Jim Shamp.
December 4-5
SE BIO Investor Forum
(Palm Beach, Fla.)
February 16-17, 2009
Biotech 2009
(Raleigh)
May 18-21, 2009
BIO International Convention
(Atlanta)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, November 6, 2008. For the latest headlines from North Carolina’s biotechnology industry, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.